Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
“The immuno-oncology revolution is now about 15 years into clinical reality,” said Carl June, MD, FAACR, director of the...
Researchers have made great progress in understanding cancer biology and advancing the science of prevention, treatment, and survivorship. However,...
As we keep an eye out for those promised May flowers, we bring you the latest round of Editors’...
The story is familiar: A patient is diagnosed with cancer, they begin treatment, and, after a few months, they...
When diagnosed early, lung cancer can often be treated with surgical resection. However, patients with resectable non-small cell lung...
Progress against cancer has been fueled not by a single discipline or a sole blockbuster discovery, but by incremental...
When a patient receives a cancer diagnosis, doctors may perform genetic testing to determine what drives the cancer, potentially...
The COVID-19 pandemic has provided a strong reminder for the scientific community about the importance of public understanding and...
In a 1735 letter to the citizens of Philadelphia about the need to tighten the city’s fire safety measures,...
Guest post by Ned Sharpless, MD, FAACR As I announced a short time ago, I have decided to step...